- Vaginal Microbiome Dysbiosis is Associated with the Different Cervical Disease Status
-
Yingying Ma , Yanpeng Li , Yanmei Liu , Le Cao , Xiao Han , Shujun Gao , Chiyu Zhang
-
J. Microbiol. 2023;61(4):423-432. Published online April 3, 2023
-
DOI: https://doi.org/10.1007/s12275-023-00039-3
-
-
1,378
View
-
8
Download
-
20
Web of Science
-
24
Crossref
-
Abstract
PDF
-
Vaginal microbiome composition was demonstrated to be associated with cervical disease. The colonization characteristics
of vaginal microbes and their association with the different cervical disease status, especially cervical cancer (CC), are
rarely investigated. In this cross-sectional study, we characterized the vaginal microbiome of women with different status of
cervical diseases, including 22 NV + (normal tissue with HPV infection), low-grade squamous intraepithelial lesion (LSIL,
n = 45), high-grade squamous intraepithelial lesion (HSIL, n = 36) and CC (n = 27) using bacterial 16S DNA sequencing.
Thirty HPV-negative women with normal tissue were used as the control group. We found that higher diversity of microbiome
with gradual depletion of Lactobacillus, especially L. crispatus, was associated with the severity of cervical disease.
High-risk HPV16 infection was associated with higher microbiome diversity and depletion of Lactobacillus in high-grade
cervical diseases (i.e. HSIL and CC). The CC group was characterized by higher levels of Fannyhessea vaginae, Prevotella,
Bacteroides, Finegoldia, Vibrio, Veillonella, Peptostreptococcus, and Dialister. Co-occurrence network analyses showed that
negative correlations were exclusively observed between Lactobacillus and other bacteria, and almost all non-Lactobacillus
bacteria were positively correlated with each other. In particular, the most diverse and complex co-occurrence network of
vaginal bacteria, as well as a complete loss of L. crispatus, was observed in women with CC. Logistic regression model
identified HPV16 and Lactobacillus as significant risk and protective factors for CC, respectively. These results suggest that
specific Lactobacillus species (e.g. L. crispatus and L. iners) can be used as important markers to target prevention measures
prioritizing HPV16-infected women and other hrHPV-infected women for test, vaccination and treat initiatives.
-
Citations
Citations to this article as recorded by 
- The Vaginal Microbiome and Host Health: Implications for Cervical Cancer Progression
María del Carmen Lagunas-Cruz, Arturo Valle-Mendiola, Isabel Soto-Cruz International Journal of Molecular Sciences.2026; 27(2): 640. CrossRef - Cell cycle gene expression and microbial profiles associated with HPV related cervical neoplasia and cervical microbiome shifts
Zahra Sadeghi, Seyed Mohammad Jazayeri, Angila Ataei Pirkooh, Abbas Rahimi Foroushani, Fariba Yarandi, Masoud Alebouyeh, Ronak Bakhtiari Scientific Reports.2026;[Epub] CrossRef - The Vaginal Microbiota of Adult Malagasy Women of Reproductive Age in the Marovoay District: First Characterization and Exploration of Associations With Human Papillomavirus and Schistosoma haematobium Infections
Jana Christina Hey, Johanna Saalfrank, Tahinamandranto Rasamoelina, Anjarasoa Ravo Razafindrakoto, Matthieu Razafindralava, Valeri Gildas Rajaoniarivo, Jean-Marc Kutz, Sonya Ratefiarisoa, Thorsten Thye, Irina Kislaya, Simon Graspeuntner, Zoly Rakotomalala The Journal of Infectious Diseases.2026; 234(1): e90. CrossRef - Impact of prebiotics, probiotics, and postbiotics on maternal and fetal health: mechanisms, efficacy, and safety across pregnancy
Kit-Leong Cheong, Te Pan, Min Wang, Dongju Wang, Saiyi Zhong Pediatric Research.2026;[Epub] CrossRef - Multi-kingdom cervical microbiome structure in health and dysbiosis: a cross-sectional study from Kazakhstan
Aidana Rakhmankulova, Samat Kozhakhmetov, Artur Kovenskiy, Nurislam Mukhanbetzhanov, Nurlubek Katkenov, Zharkyn Jarmukhanov, Milan Terzic, Gauri Bapayeva, Talshyn Ukybassova, Gulzhanat Aimagambetova, Yevgeniy Kim, Berik Primbetov, Balkenzhe Imankulova, Ku Frontiers in Microbiology.2026;[Epub] CrossRef - The Vaginal Microbiome Across the Continuum from HPV Infection to Cervical Cancer: A Narrative Review
Xiaodie Zhou, Jiaqi Hu, Ruoyu Zhou, Yi Lu, Xuan Du, Yipei Chen, Qingling Ren, Yue Han Microorganisms.2026; 14(10): 2158. CrossRef - Advancements in the Vaginal Microenvironment and Regression of High-Risk Human Papillomavirus
Na He, Cunjian Yi, Qingsong Zeng, Wumei Jing, Wenrong He Indian Journal of Microbiology.2025; 65(4): 1771. CrossRef - Vaginal Microbiota and Local Immunity in HPV-Induced High-Grade Cervical Dysplasia: A Narrative Review
Helena C. J. Schellekens, Lotte M. S. Schmidt, Servaas A. Morré, Edith M. G. van Esch, Peggy J. de Vos van Steenwijk International Journal of Molecular Sciences.2025; 26(9): 3954. CrossRef - The Vaginal Microbiota, Human Papillomavirus, and Cervical Dysplasia—A Review
Justė Kazlauskaitė, Guoda Žukienė, Vilius Rudaitis, Daiva Bartkevičienė Medicina.2025; 61(5): 847. CrossRef - Nanoparticles and the Vaginal Microbiota: Diagnostic and Therapeutic Innovations in Human Papilloma Virus-associated Cervical Cancer – A Systematic Review
Saranya Velmurugan, Karthikeyan Ganesan, Archana Rajasundaram, C. Thangam, Rozario Cyril, Gowtham Kumar Subbaraj Nigerian Postgraduate Medical Journal.2025; 32(1): 1. CrossRef - Exploring the Interplay Between Cervicovaginal Microbiome, HPV Infection, and Cervical Intraepithelial Neoplasia in Taiwanese Women
Chung‐Yao Yang, Ting‐Chang Chang, Yi‐Tzu Lee, Ting‐Ying Shih, Chang‐Wei Li, Chao‐Min Cheng Journal of Medical Virology.2025;[Epub] CrossRef - A nomogram prediction model for embryo implantation outcomes based on the cervical microbiota of the infertile patients during IVF-FET
Yanan Wu, Lingyun Shi, Zili Jin, Wenjun Chen, Fuxin Wang, Huihua Wu, Hong Li, Ce Zhang, Rui Zhu, Simone Filardo Microbiology Spectrum.2025;[Epub] CrossRef - The Interplay Between Cervicovaginal Microbiota Diversity, Lactobacillus Profiles and Human Papillomavirus in Cervical Cancer: A Systematic Review
Giosuè Giordano Incognito, Carlo Ronsini, Vittorio Palmara, Paola Romeo, Giuseppe Vizzielli, Stefano Restaino, Marco La Verde, Orazio De Tommasi, Marco Palumbo, Stefano Cianci Healthcare.2025; 13(6): 599. CrossRef - Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis
Qin Wen, Shubin Wang, Yalan Min, Xinyi Liu, Jian Fang, Jinyi Lang, Meihua Chen BMC Women's Health.2025;[Epub] CrossRef - Quantification of Lactobacillus spp. of interest for the study of the vaginal microbiota
Vivian Heimbecker, Bárbara Pontarollo Dal Santos, Ana Paula Thomaz, Keite da Silva Nogueira, Camila Marconi Journal of Microbiological Methods.2025; 236: 107158. CrossRef - Associations of Atopobium, Garderella, Megasphaera, Prevotella, Sneathia, and Streptococcus with human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis
Yan Peng, Qin Tang, Shiming Wu, Chengzhi Zhao BMC Infectious Diseases.2025;[Epub] CrossRef - Role of Vaginal and Gut Microbiota in Human Papillomavirus (HPV) Progression and Cervical Cancer: A Systematic Review of Microbial Diversity and Probiotic Interventions
Hrishikesh D Pai, Rashmi Baid, Nandita P Palshetkar, Rishma Pai, Arnav Pai, Rohan Palshetkar Cureus.2025;[Epub] CrossRef - Translating the vaginal microbial landscape: a connecting link between bacterial vaginosis and preeclampsia
Devanshi Gajjar, Sriram Seshadri Exploration of Immunology.2025;[Epub] CrossRef - Lactobacillus-Dominated Cervical Microbiota Revealed by Long-Read 16S rRNA Sequencing: A Greek Pilot Study
Despina Vougiouklaki, Sophia Letsiou, Konstantinos Ladias, Aliki Tsakni, Iliana Mavrokefalidou, Zoe Siateli, Panagiotis Halvatsiotis, Dimitra Houhoula Genes.2025; 17(1): 18. CrossRef - Human papillomavirus: genetic diversity, vaginal microbiota, and local immunity in cervical intraepithelial neoplasia
Volha P. Lohinava, Natalia I. Shevchenko, Elena L. Gasich Journal of microbiology, epidemiology and immunobiology.2025; 102(6): 750. CrossRef - Cervicovaginal microbiome alters transcriptomic and chromatin accessibility signatures across cervicovaginal epithelial barriers
Lauren Anton, Ana G. Cristancho, Briana Ferguson, Jacques Ravel, Michal A. Elovitz Microbiome.2025;[Epub] CrossRef - Vaginal Microbiome and Pregnancy Complications: A Review
Angeliki Gerede, Konstantinos Nikolettos, Eleftherios Vavoulidis, Chrysoula Margioula-Siarkou, Stamatios Petousis, Maria Giourga, Panagiotis Fotinopoulos, Maria Salagianni, Sofoklis Stavros, Konstantinos Dinas, Nikolaos Nikolettos, Ekaterini Domali Journal of Clinical Medicine.2024; 13(13): 3875. CrossRef - Research Progress on Related Factors of Cervical High-Grade Squamous Intraepithelial Lesions
红颖 王 Advances in Clinical Medicine.2023; 13(12): 20536. CrossRef - Role of the vaginal microbiome in miscarriage: exploring the relationship
Marwa Saadaoui, Parul Singh, Osman Ortashi, Souhaila Al Khodor Frontiers in Cellular and Infection Microbiology.2023;[Epub] CrossRef
- Improved Prediction of Coreceptor Usage and Phenotype of HIV-1 Based on Combined Features of V3 Loop Sequence Using Random Forest
-
Shungao Xu , Xinxiang Huang , Huaxi Xu , Chiyu Zhang
-
J. Microbiol. 2007;45(5):441-446.
-
DOI: https://doi.org/2592 [pii]
-
-
Abstract
PDF
-
HIV-1 coreceptor usage and phenotype mainly determined by V3 loop are associated with the disease progression of AIDS. Predicting HIV-1 coreceptor usage and phenotype facilitates the monitoring of R5-to-X4 switch and treatment decision-making. In this study, we employed random forest to predict HIV-1 biological phenotype, based on 37 random features of V3 loop. In comparison with PSSM method, our RF predictor obtained higher prediction accuracy (95.1% for coreceptor usage and 92.1% for phenotype), especially for non-B non-C HIV-1 subtypes (96.6% for coreceptor usage and 95.3% for phenotype). The net charge, polarity of V3 loop and five V3 sites are seven most important features for predicting HIV-1 coreceptor usage or phenotype. Among these features, V3 polarity and four V3 sites (22, 12, 18 and 13) are first reported to have high contribution to HIV-1 biological phenotype prediction.
|